{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:06:29Z","timestamp":1793502389231,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.037","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:01:51Z","timestamp":1787295711000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-8557","authenticated-orcid":false,"given":"Caspian H.","family":"Oliai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-3247","authenticated-orcid":false,"given":"Rasmus T.","family":"Hoeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Muffly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer A.","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohtesh S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7924-2915","authenticated-orcid":false,"given":"Robert","family":"Lowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9949-3615","authenticated-orcid":false,"given":"Sagar S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagirathbhai","family":"Dholaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Pantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-4796","authenticated-orcid":false,"given":"Joseph P.","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-3790","authenticated-orcid":false,"given":"Alexandra","family":"Gomez-Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Faramand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-7002","authenticated-orcid":false,"given":"Jennifer","family":"Holter-Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M. Jimenez","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-3732","authenticated-orcid":false,"given":"M. Scott","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pavlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel B.","family":"Fernhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4993-5106","authenticated-orcid":false,"given":"J. Scott","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-853X","authenticated-orcid":false,"given":"Everett H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.08.037_bib0001","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179944","article-title":"Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation","volume":"134","author":"Kean","year":"2024","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.037_bib0002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17474086.2023.2273847","article-title":"The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Maurer","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtct.2026.08.037_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","article-title":"Pathophysiology of GvHD and other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2024.100020","article-title":"Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202","volume":"1","author":"Newell","year":"2024","journal-title":"Blood Vessel Thromb Hemost"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.037_bib0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"issue":"25","key":"10.1016\/j.jtct.2026.08.037_bib0006","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bolanos-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.037_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/JCO.21.02293","article-title":"Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies","volume":"40","author":"Luznik","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.037_bib0008","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/bloodadvances.2021005847","article-title":"Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial","volume":"6","author":"Broers AEC","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa2503189","article-title":"Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin","volume":"393","author":"Curtis","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.037_bib0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy\u2014a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.037_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2020-142974","article-title":"Orca-T, a precision Treg-engineered donor product, prevents acute Gvhd with less immunosuppression in an early multicenter experience with myeloablative HLA-matched transplants","volume":"136","author":"Meyer","year":"2020","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1016\/j.jtct.2026.08.037_bib0012","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/S2152-2650(22)01672-X","article-title":"CT-524 Orca-T, a precision engineered allograft, results in high GVHD-free and relapse-free survival following myeloablative conditioning for hematological malignancies","volume":"22","author":"Meyer","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.037_bib0013","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.2025031313","article-title":"Orca-T vs allogeneic hematopoietic stem cell transplantation (precision-T): a multicenter, randomized phase 3 trial","volume":"147","author":"Meyer","year":"2026","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.037_bib0014","article-title":"Outcomes of allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia: a systematic review","volume":"17","author":"Mohamed Ahmed","year":"2025","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.037_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.07.021","article-title":"Post-transplantation cyclophosphamide versus tacrolimus and methotrexate graft-versus-host disease prophylaxis for HLA-matched donor transplantation","volume":"28","author":"Mehta","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.037_bib0016","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2015-10-672071","article-title":"Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation","volume":"127","author":"Mielcarek","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0017","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbmt.2016.12.636","article-title":"Post-transplant cyclophosphamide and tacrolimus-mycophenolate mofetil combination prevents graft-versus-host disease in allogeneic peripheral blood hematopoietic cell transplantation from HLA-matched donors","volume":"23","author":"Carnevale-Schianca","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.037_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.05.023","article-title":"Posttransplantation cyclophosphamide- and sirolimus-based graft-versus-host-disease prophylaxis in allogeneic stem cell transplant","volume":"27","author":"Greco","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.037_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.05.009","article-title":"PTCY and tacrolimus for GVHD prevention for older adults undergoing HLA-matched sibling and unrelated donor AlloHCT","volume":"28","author":"Salas","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/pharmrev.120.000121","article-title":"The nitrogen mustards","volume":"74","author":"Highley","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.037_bib0021","article-title":"Post-transplant cyclophosphamide in matched donor transplantation: are we there yet?","volume":"73","author":"Lazzari","year":"2025","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.jtct.2026.08.037_bib0022","article-title":"Kidney function after hematopoietic cell transplantation with Orca-T, cyclophosphamide, or methotrexate graft-versus-host disease prophylaxis: a single-center retrospective study","volume":"32","author":"Ziolkowski","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.037_bib0023","doi-asserted-by":"crossref","unstructured":"Dul\u00e9ry R, Mohty R, Labopin M, et al. Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation. 2021;3(2):250-259.","DOI":"10.1016\/j.jaccao.2021.02.011"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.037_bib0024","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/bloodadvances.2022008792","article-title":"Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant","volume":"7","author":"P\u00e9rez-Valencia","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0025","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/bloodadvances.2024014781","article-title":"PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation","volume":"9","author":"Desai","year":"2025","journal-title":"Blood Adv"},{"issue":"28","key":"10.1016\/j.jtct.2026.08.037_bib0026","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.24.00184","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors","volume":"42","author":"Shaffer","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.037_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.09.001","article-title":"Bacterial bloodstream infections in patients undergoing allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"28","author":"Salas","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.037_bib0028","article-title":"Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant","author":"Siegel","year":"2025","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.037_bib0029","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jtct.2021.07.023","article-title":"Increased infections and delayed CD4(+) T cell but faster B cell immune reconstitution after post-transplantation cyclophosphamide compared to conventional GVHD prophylaxis in allogeneic transplantation","volume":"27","author":"Khimani","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.037_bib0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-023-02131-z","article-title":"Post-transplantation cyclophosphamide is associated with increased bacterial infections","volume":"59","author":"Ustun","year":"2024","journal-title":"Bone marrow transplant"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.08.037_bib0031","article-title":"Factors associated with platelet engraftment following allogeneic hematopoietic cell transplantation","volume":"144","author":"Trunk","year":"2024","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.037_bib0032","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ajh.27741","article-title":"Poor engraftment after posttransplant cyclophosphamide graft-versus-host disease prophylaxis in patients with myelofibrosis","volume":"100","author":"Kim","year":"2025","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.037_bib0033","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.jtct.2025.01.215","article-title":"Suboptimal engraftment and toxicity after post-transplant cyclophosphamide","volume":"31","author":"Scarpetti","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"10.1016\/j.jtct.2026.08.037_bib0034","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.2022017982","article-title":"Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD","volume":"141","author":"Lohmeyer","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.037_bib0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2007-07-103895","article-title":"The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation","volume":"111","author":"Nguyen","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0036","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3324\/haematol.2024.285921","article-title":"Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study","volume":"110","author":"Kerbauy","year":"2025","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.037_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.06.008","article-title":"Phase II study of myeloablative 7-8\/8-matched allotransplantation with post-transplantation cyclophosphamide, tacrolimus, and mycophenolate mofetil","volume":"29","author":"Jurdi","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"34","key":"10.1016\/j.jtct.2026.08.037_bib0038","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021571","article-title":"A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation","volume":"99","author":"Lee","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.037_bib0039","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.037_bib0040","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/bloodadvances.2024013074","article-title":"Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis","volume":"8","author":"Farhadfar","year":"2024","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.037_bib0041","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.037_bib0042","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"10.1016\/j.jtct.2026.08.037_bib0043","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1182\/bloodadvances.2023009786","article-title":"Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic","volume":"7","author":"Devine","year":"2023","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.08.037_bib0044","article-title":"Safe and effective combination of donor-derived, allogeneic CD19\/CD22-CAR T cells with myeloablative graft-engineered allo-HCT for high-risk B-ALL","volume":"144","author":"Muffly","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.08.037_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2025-111","article-title":"Allogeneic HSC and regulatory T cell (Orca-T) engineered cell therapy following reduced intensity conditioning: Results of a single center Phase 1 study","volume":"146","author":"Villar-Prados","year":"2025","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:13:27Z","timestamp":1789384407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S2666636726006780"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.037","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}